| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Revenue | $912.0M | +9.2% |
| Cost of Revenue | $657.5M | +2.8% |
| Gross Profit | $254.5M | +29.9% |
| R&D Expense | $67.6M | -33.2% |
| SG&A Expense | $154.4M | -7.4% |
| Operating Income | -$19.6M | +86.7% |
| Interest Expense | $33.4M | -4.5% |
| Pre-tax Income | -$50.4M | +73.4% |
| Income Tax | -$12.5M |
| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $309.1M | +71.2% |
| Accounts Receivable | $109.6M | -1.7% |
| Inventory | $332.9M | -0.7% |
| Current Assets | $1.06B | +10.9% |
| Total Assets | $2.43B | +2.3% |
| Current Liabilities | $300.4M | +28.1% |
| Total Liabilities | $961.3M | +6.1% |
| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $138.9M | +130.0% |
| Capital Expenditures | $19.8M | -42.3% |
| Investing Cash Flow | -$13.5M | +60.6% |
| Financing Cash Flow | $1.4M | -98.3% |
| Free Cash Flow | $119.0M | +356.3% |
| +75.8% |
| Net Income | -$37.9M | +72.5% |
| EPS (Basic) | -$0.65 | +72.7% |
| EPS (Diluted) | -$0.65 | +72.7% |
| Stockholders' Equity |
| $1.47B |
| +0.0% |